7-Chloro-1,2,3,4-Tetrahydro-Benzo[B]Azepin-5-One | CAS:160129-45-3

We serve 7-Chloro-1,2,3,4-Tetrahydro-Benzo[B]Azepin-5-One CAS:160129-45-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
7-Chloro-1,2,3,4-Tetrahydro-Benzo[B]Azepin-5-One

Chemical Name:7-Chloro-1,2,3,4-Tetrahydro-Benzo[B]Azepin-5-One
CAS.NO:160129-45-3
Synonyms:7-Chloro-1,2,3,4-Tetrahydro-Benzo[B]Azepin-5-One
7-Chloro-3,4-dihydro-1H-benzo[b]azepin-5(2H)-one
7-Chloro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one
7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 356.5±41.0 °C at 760 mmHg
Molecular Formula C10H10ClNO
Molecular Weight 195.645
Flash Point 169.4±27.6 °C
 
Specification:
Appearance:Yellow crystalline powder
Assay(HPLC):≥99.0%
Melting rang:103-104°C
Related compounds:≤0.5%
Loss on drying:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Tolvaptan(CAS:150683-30-0).



Contact us for information like 7-Chloro-1,2,3,4-Tetrahydro-Benzo[B]Azepin-5-One chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one Use and application,7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one technical grade,usp/ep/jp grade.


Related News: In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China.Methyl 4-(4-fluorophenyl)-6-isopropyl-2-[(N-methyl-N-methylsulfonyl)amino]pyrimidine-5-carboxylate manufacturer Here’s what we can tell you so far:3-Bromo-6-fluoro-2-methylpyridine supplier In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry”, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. .4-Acetylbenzoic acid vendor The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm.